April 30, 2021
China Medical System company(CMS) visited Quacell Biotechnology
Mr Lin Gang, Chairman of the Board of Directors of CMS Co., Ltd., Mr Wang Gang, General Manager of CMS Health Fund, and Mr Zhou Haiyang, Deputy General Manager, visited QuaCell Biotechnology Co., Ltd. (Quacell Biotechnology) and for investigation.
During the meeting, Mr Wu Fan, Vice-President and Chief Operating Officer of Quacell introduced the core technologies of the company's development history to CMS. After that, the CMS chairman Mr Lin Gang also gave a detailed presentation on the development and future blueprint of CMS Pharmaceutical. Both sides expressed that they are highly complementary in terms of business development, and are expected to reach cooperation in multiple business levels in the future, and have formed preliminary cooperation intention.
Moreover, the attendants included the founder of Dingxin Gene Co., Ltd Mr Zhou Rui, and Zhongshan Torch Huaying Investment Co., Ltd. (hereinafter referred to as the "Torch TDF") and the leader of National Health Base. The conference presented and introduced the health industry environment and investment environment of Zhongshan. Dr Pan Honghui, the Chairman and CEO of Quacell Biotechnology, and Dr Yuan Jun, Vice-President and Chief Technology Officer, attended the meeting and reception.
Congratulation!! | Quacell won the title of excellent enterprise in the 10th China Innovation and Entrepreneurship Competition (growth group)!
News | QuaCell Biotechnology announced that it had completed nearly 200 million yuan of round B financing
Dr. Poon, CEO of QuaCell Biotechnology, Co., Ltd. was honored to be elected Associate Editor of RE: GEN Open
Conclusion | Biofuture2021
BIG EVENETS. Day 2 | Biofuture 2021